News

Varenicline helps smokers with stably treated depression

View on the News

Trial may be helpful in understanding of non-psychiatrically ill smokers with history of depression

Dr. Vera DePalo

Dr. Vera DePalo, FCCP, comments: Smoking is a habit that contributes to several disease states and many strategies are employed to help with smoking cessation. Practitioners continue to search for the intervention that can aid the patient in success. As with all pharmacologic therapies,the prescriber considers the unintended side effects.
This industry-funded trial may be helpful to the practitioner's understanding of the possible options in non-psychiatrically ill smokers with a history of depression.


 

FROM ANNALS OF INTERNAL MEDICINE

*CORRECTION, 10/10/13: An earlier version of this article misstated the citation for the journal article referenced in the story.

Pages

Recommended Reading

New measure of depression remission looks promising
MDedge Internal Medicine
Selegiline transdermal system promising for social phobia
MDedge Internal Medicine
Low-dose paroxetine approved for hot flashes
MDedge Internal Medicine
Aphasic stroke patients' mood lifted by behavioral therapy
MDedge Internal Medicine
Levomilnacipran SR for major depression also improves attention deficits
MDedge Internal Medicine
Suicide risk in the military similar to that in civilian populations
MDedge Internal Medicine
CRTC1 polymorphisms affect BMI, novel study finds
MDedge Internal Medicine
Depression, some antidepressants linked to high C. difficile risk
MDedge Internal Medicine
Depression linked to accelerated cognitive decline in diabetes
MDedge Internal Medicine
Depression in pediatric SLE matches average rates
MDedge Internal Medicine